Ovarian Cancer Trial, Not Yet Recruiting NCT07267780 Sponsor: National Cancer Institute, Naples Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Not Yet Recruiting

NCT07267780
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People included in the retrospective (past records) part of the study must have had a diagnosis of advanced or returning gynaecological cancer that involved major blood vessels and required surgery to remove or reconstruct those vessels — this includes ovarian, cervical, endometrial, or vulvar cancer, or uterine and other sarcomas affecting blood vessels.
  • For the retrospective part, major blood vessel involvement must have been confirmed by scans taken before surgery or by descriptions recorded during surgery.
  • For the retrospective part, the person must have undergone combined cancer and vascular surgery between 1 January 2017 and 31 August 2025.
  • For the retrospective part, a formal data privacy assessment (called a DPIA) must have been approved for the use of past records — records of deceased or untraceable patients may also be included to ensure the study results are not skewed, in line with Italian privacy law, except where a patient explicitly objected before their death.
  • People included in the prospective (future/ongoing) part of the study must be 18 years of age or older.
  • For the prospective part, the person must be considered suitable for combined cancer and vascular surgery for advanced or returning gynaecological cancer with blood vessel involvement — including ovarian, cervical, endometrial, or vulvar cancer, or uterine and other sarcomas.
  • For the prospective part, major blood vessel involvement must be confirmed by scans taken before surgery or by descriptions recorded during surgery.
  • For the prospective part, the person must have signed a consent form agreeing to take part in the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People under 18 years of age.
  • People with early-stage gynaecological cancers where combined cancer and vascular surgery is not considered appropriate.
  • People who need vascular surgery because a blood vessel was accidentally damaged during an operation, where the damage was not caused by the tumour itself.
  • People who have previously had vascular surgery for reasons unrelated to this study, in order to avoid overlapping data.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0000000000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
National Cancer Institute, Naples
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 December 2030

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Overall Survival (OS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov